| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 02/18/2004 | EP1169301B1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 02/18/2004 | CN1476434A Novel compounds |
| 02/18/2004 | CN1476431A Process for preparing distamycin derivatives |
| 02/18/2004 | CN1476430A Delta 1-pyrrolines used as pesticides |
| 02/18/2004 | CN1476429A EP4 receptor selective agonists in treatment of osteoporosis |
| 02/18/2004 | CN1476428A Delta 1-pyrrolines for use as pesticides |
| 02/18/2004 | CN1138757C Prepn. of N-bromosuccinimide |
| 02/17/2004 | US6693202 Multibinding ligands containing such as amine, amide, ester, hydroxyl, carbamate, urea and/or imino functionality |
| 02/17/2004 | US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter |
| 02/17/2004 | US6693193 Coupling an n- and o-protected 2,3-dihydroxy-pyrrolidine to the 2-position and deprotecting |
| 02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
| 02/17/2004 | US6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| 02/17/2004 | US6693092 Herbicides; pesticides |
| 02/12/2004 | WO2004013282A2 Bis (amino acid) molecular scaffolds |
| 02/12/2004 | WO2004013098A1 Novel gamma-lactams as beta-secretase inhibitors |
| 02/12/2004 | WO2004013097A1 Process for the preparation of amino-pyrrolidine derivatives |
| 02/12/2004 | WO2004013094A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/12/2004 | WO2004012732A2 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 02/12/2004 | WO2004012731A1 Pyrrolidine derivatives as tryptase inhibitors |
| 02/12/2004 | WO2003103604A3 Gamma lactams as prostaglandin agonists and use thereof |
| 02/12/2004 | WO2003088909A3 Methods for modulating phototoxicity |
| 02/12/2004 | WO2003070665A3 Desolvating solvates of atorvastatin hemi-calcium |
| 02/12/2004 | WO2002100344A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 02/12/2004 | US20040030155 One pot process; halogenation an acid; reacting with base |
| 02/12/2004 | US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects |
| 02/12/2004 | US20040030129 NF-kappaB inhibitor comprising phenylmethyl benzoquinone as an active ingredient |
| 02/12/2004 | US20040030072 Using coordination catalyst |
| 02/12/2004 | US20040029951 cyclooxygenase-2 (COX-2) inhibitors; Non-steroidal anti-inflammatory drugs (NSAIDs) with side effect reduction; N-propyl-3-(4-methylsulfonylphenyl)-4-(4-chlorophenyl)-2,5-dihydropyrrole-2-one for example; rheumatoid arthritis |
| 02/12/2004 | US20040029933 Substituted phenylacetic acids |
| 02/12/2004 | US20040029887 Cardiovascular disorders; antiinflammatory agents; central nervous system diosrders; psychological disorders |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029814 Cathepins inhibitor; antiinflammatory agents; antiarthritic agents |
| 02/12/2004 | US20040029810 Process for preparing distamycin derivatives |
| 02/12/2004 | US20040029735 Substituted herbicidal phenyluracils |
| 02/12/2004 | CA2494404A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/12/2004 | CA2492830A1 Pyrrolidine derivatives as tryptase inhibitors |
| 02/11/2004 | EP1387824A1 Method for purifying a raw melt of at least one monomer by crystallization |
| 02/11/2004 | EP1387820A2 Method for the production of a purified melt of at least one monomer |
| 02/11/2004 | EP1387679A1 Sulfonamides |
| 02/11/2004 | EP1299356B1 Novel compounds |
| 02/11/2004 | EP1098866B1 Method for producing ortho-alkylated benzoic acid derivatives |
| 02/11/2004 | EP0936912B1 Inhibitors of cysteine protease |
| 02/11/2004 | CN1474810A Substituted urea neuropeptide YY5 antagonists |
| 02/11/2004 | CN1474809A Cyanopyrolidine derivatives |
| 02/11/2004 | CN1473814A Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol |
| 02/10/2004 | US6689909 Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 02/10/2004 | US6689890 Efficient lactam synthesis |
| 02/10/2004 | US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase |
| 02/10/2004 | US6689174 N-benzyl-p-phenylenediamine-derivatives containing coloring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives |
| 02/05/2004 | WO2004011431A1 Pleuromutilin derivatives as antimicrobbials |
| 02/05/2004 | WO2004011423A2 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 02/05/2004 | WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 02/05/2004 | WO2004010945A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 02/05/2004 | WO2004010943A2 Substituted benzanilides as modulators of the ccr5 receptor |
| 02/05/2004 | WO2003075857A3 Amino-methyl substituted tetracycline compounds |
| 02/05/2004 | WO2002100886A8 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 02/05/2004 | WO2002041834A8 Atorvastatin hemi-calcium form vii |
| 02/05/2004 | US20040024226 Reacting atorvastatin lactone, methanol, and methyl tert-butyl ether with sodium sodium hydroxide to form ring-opened salt; drying isolated product in vacuum pan dryer with continuously rotating agitator |
| 02/05/2004 | US20040024215 Such as 4'-trifluoromethyl-biphenyl-2-carboxylic acid(4-(4-(alpha-methyl-benzyl)-piperazin-1-yl)-phenyl)-amide; apoprotein B-100 (apoB-100) and microsomal triglyceride transfer protein (MTP) |
| 02/05/2004 | US20040024210 New compounds |
| 02/05/2004 | US20040024132 A free radical polymerization in presence of a sulfur based chain transfer agents, controlling during the synthesis of polystyrene, polymethyl acrylate, polymethyl methacrylate |
| 02/05/2004 | US20040024059 Novel pleuromutilin derivatives |
| 02/05/2004 | US20040024046 By precipitating the atorvastatin using a solvent of a second type from a solution of atorvastatin which is provided with a solvent of a first type |
| 02/05/2004 | US20040023945 Cyclic amp-specific phosphodiesterase inhibitors |
| 02/05/2004 | US20040023806 Agrochemicals in agriculture for controlling acarids and insects and for preventing the infestation of crop plants by phytopathogenic fungi. |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/05/2004 | DE10022829B4 p-Aminophenol-Derivate und diese Verbindungen enthaltende Haarfärbemittel p-aminophenol derivatives and compositions containing these compounds Hair dyes |
| 02/05/2004 | CA2495167A1 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 02/05/2004 | CA2493156A1 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 02/04/2004 | EP1386913A1 Pyrrole derivative |
| 02/04/2004 | EP1386912A1 Cyclic amidine derivative |
| 02/04/2004 | EP1385841A1 Sulfonamides |
| 02/04/2004 | EP1385840A1 Sulfonamides |
| 02/04/2004 | EP1385822A1 Aminopyrrolidine sulfonamides as serine protease inhibitors |
| 02/04/2004 | EP1385820A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 02/04/2004 | EP1385510A1 Prodigiosin composition for the treatment of rheumatic arthritis |
| 02/04/2004 | EP1385508A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/04/2004 | EP1385507A1 Sulfonamides |
| 02/04/2004 | EP1203585A4 Anti-ischemic agent |
| 02/04/2004 | EP1115697B1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 02/04/2004 | CN1473150A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/04/2004 | CN1473145A Method of resolving optical isomers of amino acid derivative |
| 02/04/2004 | CN1473034A Photo-labile pro-fragrance conjugates |
| 02/04/2004 | CN1137095C Preparation of i(N)-substituted-hydroxycycloalkylamine derivatives |
| 02/03/2004 | US6686477 Multistep chemical synthesis, including asymmetric hydrogenation of a lactam-enamide to produce an intermediate that can be used to make unspecified pharmaceuticals |
| 02/03/2004 | US6686390 Compounds having antiinflamatory activity: process for their preparation and pharmaceutical compositions containing them |
| 02/03/2004 | US6686386 Combating photoinduced or chronological ageing of skin with retenoic acid receptor agonist |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686350 Cell adhesion inhibitors |
| 02/03/2004 | US6685617 4-(((-1-carboxy-2-(4-((2,6-dichlorobenzoyl)amine)phenyl)ethyl) amino)carbonyl)-3-oxo-3-thiazolidinebutanoic acid, used as antagonists for cellular adhesion molecules, and administered as antiinflammatory agents |
| 01/29/2004 | WO2004009544A1 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 01/29/2004 | WO2004009533A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/29/2004 | WO2004009531A1 Acetylenic compounds useful in treating inflammatory disorders |
| 01/29/2004 | WO2004009527A1 Materials and methods for treating hypercholesterolemia |
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/29/2004 | WO2003053923A3 Pyrrolidine derivatives as prostaglandin modulators |
| 01/29/2004 | WO2003000180A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/29/2004 | US20040019239 Catalytic compositions and methods for asymmetric aldol reactions |
| 01/29/2004 | US20040019224 Low shrinkage thermosetting resin compositions and methods of use therefor |